Continuing interesP4 in the development of analogues of the anticancer drug cisplatin (11, which, for example, are less toxic, have increased clinical efficacy and have a broader spectrum of activity than the parent compound, and recent report^^,^ of analogues containing diamino carbohydrate derivatives, led us to prepare four new complexes 2-5, each of which contain a diaminodideoxytetritl derivative in place of the amine ligands ...